125 related articles for article (PubMed ID: 5037437)
41. Immunologic and immunotherapeutic studies with human sarcomas.
Eilber FR; Morton DL
Surg Forum; 1970; 21():127-9. PubMed ID: 4999008
[No Abstract] [Full Text] [Related]
42. Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k origin.
Rogers MJ; Carbone G; Ballinari D; Cattaneo M; Parmiani G
Transplant Proc; 1981 Dec; 13(4):1774-81. PubMed ID: 7330966
[No Abstract] [Full Text] [Related]
43. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization.
Saito T
Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376
[No Abstract] [Full Text] [Related]
44. [Specific humoral immunity in experimental ornithosis in guinea pigs. 1. Complement fixation antibodies and hemagglutinins].
Vishniakova LA
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1970; 37():129-35. PubMed ID: 5537964
[No Abstract] [Full Text] [Related]
45. [Detection of antibodies to T-antigens of different origin in sera of monkeys with Rous sarcoma and monkeys infected with adenovirus type 122].
Adzhigitov FI; Degtiarenko VI; Zatsepin NI; Pertaia AV; Gubeladze DA
Dokl Akad Nauk SSSR; 1972 Feb; 202(6):1432-4. PubMed ID: 4334994
[No Abstract] [Full Text] [Related]
46. Use of covalently bound cord factor analog to increase tumor immunogenicity.
Eggers AE; Tarmin L; Ginsburg S
J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
[TBL] [Abstract][Full Text] [Related]
47. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
[No Abstract] [Full Text] [Related]
48. [Current topics on tumor immunology].
Tachibana T
Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
[TBL] [Abstract][Full Text] [Related]
49. [Immunogenetic study of tumor growth in inbred rats].
Urizar LA; Ballina JC; Amerio N; Morini JC; Rabasa SL
Medicina (B Aires); 1982; 42(4):403-8. PubMed ID: 15171022
[No Abstract] [Full Text] [Related]
50. [On the immunology of guinea pig tumors induced by Rous sarcoma virus].
Leĭkina FI
Vopr Virusol; 1967; 12(6):716-20. PubMed ID: 4304898
[No Abstract] [Full Text] [Related]
51. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
De Leo AB; Becker M; Lu L; Law LW
Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
[TBL] [Abstract][Full Text] [Related]
52. ["Micro-assay" for the serologic determination of tumor cell antibodies: preliminary results with chemically-induced sarcoma in mice and tumor-cell cultures in man].
Fritze D; Kern DH; Pilch YH
Verh Dtsch Ges Inn Med; 1974; 80():1661-2. PubMed ID: 4454507
[No Abstract] [Full Text] [Related]
53. The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas.
Fisher JC; Davis RC; Mannick JA
Surgery; 1970 Jul; 68(1):150-6; discussion 156-7. PubMed ID: 10483462
[TBL] [Abstract][Full Text] [Related]
54. Immunology of sarcomas.
Mitchell MS
Clin Orthop Relat Res; 1980; (153):26-30. PubMed ID: 6160937
[TBL] [Abstract][Full Text] [Related]
55. [Antigenic structure of human and animal tumor cells].
Harlozińska A
Postepy Hig Med Dosw; 1971; 25(3):367-89. PubMed ID: 5571143
[No Abstract] [Full Text] [Related]
56. Methods of detecting cancer antigens and antitumor antibody.
McKhann CF
Fed Proc; 1965; 24(5):1033-6. PubMed ID: 4220916
[No Abstract] [Full Text] [Related]
57. Further evidence of common antigenic properties in chemically induced sarcomas of mice.
Reiner J; Southam CM
Cancer Res; 1969 Oct; 29(10):1814-20. PubMed ID: 5823950
[No Abstract] [Full Text] [Related]
58. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
59. The burn scar as an "immunologically privileged site".
Futrell JW; Myers GH
Surg Forum; 1972; 23(0):129-31. PubMed ID: 4671049
[No Abstract] [Full Text] [Related]
60. Failure of immunocytoadherence to demonstrate delayed hypersensitivity.
Roberts CI; Brandriss MW; Vaughan JH
J Immunol; 1971 Apr; 106(4):1056-64. PubMed ID: 5553713
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
